Ribbon Blender Model 42N-270 Increases Performance - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Ribbon Blender Model 42N-270 Increases Performance


Pharmaceutical Technology
Volume 38, Issue 1, pp. 16
The Ribbon Blender Model 42N-270 has a maximum working capacity of 270 cu.ft. and a full holding capacity of 300 cu.ft. The stainless steel wetted parts are polished to 150-grit finish for cleanability. The gasketed three-piece cover, safety grating, and pneumatically-operated 10” knife gate valve are all designed to facilitate ingredient charging and dust-tight operation. The double ribbon agitator is fabricated to produce a well-balanced axial and radial flow of powders while holding tightly-controlled clearances between the trough. The solid agitator shaft is driven to 20 rpm by a 100 HP TEFC motor.  All Ross Ribbon Blenders are equipped with a direct drive gear motor for improved performance and lower maintenance. With Ross-supplied controls, users receive a production-ready blender and benefit from electronic speed control, soft-start capabilities, and overload protection without any wiring hassles.

Charles Ross & Son Company

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Source: Pharmaceutical Technology,
Click here